Search PubMed⌕ Search

Biomedical subjects

A Bartolini

Publications and source records attributed to A Bartolini.

At least 109 records · Page 6Linked to original sources

Relationships between perfusion defects and static brain scan positivity in patients with ischaemic completed stroke: considerations about the origin of the increased uptake.

The relation between perfusion defects shown by radionuclide angiography and static brain scan positivity was evaluated in patients with ischaemic completed stroke at various intervals from the onset of symptoms. An inverse relation between radionuclide angiography and static scan positivity was found for the period within 15 days of the onset of symptoms. The possible relation between changes in perfusion and static brain scan positivity is discussed.

Brain Ischemia↗

Eseroline: a new antinociceptive agent derived from physostigmine with opiate receptor agonist properties. Experimental in vivo and in vitro studies on cats and rodents.

We report that eseroline, until now thought devoid of any biological action, is a potent antinociceptive agent. Its antinociceptive action is stronger than that of morphine in all tests studied and, though shorter lasting than that of the latter, has a latency of only a few minutes by subcutaneous route. Eseroline, like morphine and enkephalins, inhibits the electrically evoked twitches of the mouse vas deferens and of the guinea-pig ileum. Eseroline, moreover, releases 5-hydroxytryptamine from cat brain cortex in way similar to that of morphine and physostigmine.

Analgesics↗

Effects of morphine, physostigmine and raphe nuclei stimulation on 5-hydroxytryptamine release from the cerebral cortex of the cat.

1. The release of 5-hydroxytryptamine (5-HT) from the cerebral cortex and caudate nucleus of brainstem-transected cats and from the cerebral cortex of rats anaesthetized with urethane was determined by radioenzymatic and biological assay. 2. The stimulation of nucleus linearis intermedius of raphe doubles the basal 5-HT release in the caudate nucleus and increases it 3 fold in the cerebral cortex. The effects of the electrical stimulation of the raphe are potentiated by chlorimipramine. 3. Brain 5-HT release is greatly increased by morphine hydrochloride (6 mg/kg i.v.) and by physostigmine (100 microgram/kg i.v.), but not by DL-DOPA (50 mg/kg i.v.). 4. It is suggested that the 5-HT releasing action of physostigmine can contribute to some of its pharmacological effects such as the analgesic effect so far attributed exclusively to its indirect cholinomimetic activity. 5. The 5-HT releasing action of physostigmine seems unrelated to its anticholinesterase activity.

Animals↗

Effects of reticular stimulation, d-amphetamine and scopolamine on acetylcholine release from the hippocampus of brainstem transected cats.

The effects of i.v. and topical scopolamine and i.v. d-amphetamine were determined on spontaneous release of acetylcholine (ACh) from the dorsal hippocampus of the cat. Animals were prepared under halothane anesthesia with a brainstem transection and either intact or transected fornices. Subsequently, they were placed on room air. ACh was bioassayed using the leech muscle preparation. The amount of spontaneous ACh release varied markedly with each animal with a range of 10 to 21.5 ng/cm2/10 min. There was no mean difference in ACh release between midpontine pretrigeminal and midcollicular brainstem transections. Stimulation of the mesencephalic reticular formation with 300 H/e every sec for 9 sec produced a 28% increase in ACh release from the hippocampus in midpontine pretrigeminal brainstem transected preparations. After section of both fornices, spontaneous ACh release was not altered, although the increased release due to reticular formation stimulation was prevented. d-Amphetamine, in doses of 2.5 mg/kg given i.v., also produced an increase in ACh release from the hippocampus in midpontine pretrigeminal brainstem transected preparations. The d-amphetamine increase in ACh release from the hippocampus was also prevented when both fornices were cut. In contrast, scopolamine in doses of 0.75 mg/kg i.v. increased ACh release in midpontine pretrigeminal brainstem transected cats, either with intact or cut fornices. Topical application of scopolamine (1 microng/ml) to the hippocampus (with or without cut fornices) caused an increase in hippocampal ACh release. It is concluded that the spontaneous or evoked release of ACh from the cat hippocampus provides additional evidence for its role as a neurotransmitter.

Acetylcholine↗